MDAI vs BSX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 30, 2026

MDAI

39.3
AI Score
VS
BSX Wins

BSX

48.1
AI Score

Investment Advisor Scores

MDAI

39score
Recommendation
SELL

BSX

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDAI BSX Winner
Revenue 7.51M 10.65B BSX
Net Income -7.59M 2.24B BSX
Gross Margin 41.8% 70.1% BSX
Net Margin -101.0% 21.1% BSX
Operating Income -6.29M 2.28B BSX
ROE 63.0% 9.0% MDAI
ROA -39.0% 5.0% BSX
Total Assets 19.44M 45.22B BSX
Cash 14.00M 539.00M BSX
Current Ratio 0.90 1.24 BSX

Relative Price Performance (Last 90 Days)

MDAI 1M: -0.6% · 3M: -24.2% BSX 1M: +1.8% · 3M: -3.0%

Current Technical Phase

MDAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 42

RSI (14): 42.4 · Price: $1.57

BSX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.1%) with fading momentum, RSI 43

RSI (14): 42.7 · Price: $46.84

Fundamentals Snapshot

Metric MDAI BSX
Market Cap
Forward P/E -4.4 13.6
Trailing P/E 19.5
Revenue (TTM)
Revenue Growth -0.3% 0.1%
Gross Margin 0.4% 0.7%
Operating Margin -1.2% 0.2%
EPS -0.32 2.39
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BSX is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.